Epilepsy Comprehensive Update and Board Review

May 8-9, 2024
Westin Houston Medical Center | 1709 Dryden Rd. | Houston, Texas 77030

The Epilepsy Comprehensive Update & Board Review is an educational symposium whose aim is to educate neurologists, APPs, neurology residents, and epilepsy fellows involved in the treatment of patients with epilepsy.
This year’s course will expand attendees’ knowledge and understanding of epilepsy and will demonstrate how to offer top quality epilepsy care to patients. The event will include a series of lectures designed to prepare attendees for the Epilepsy Boards.

Some of the many exciting highlights include:

  • Focused lectures on all aspects of epilepsy care, including pharmacologic therapies, diagnostic testing, and surgical therapies.
  • Discussion of etiology and electroclinical syndromes in both adult and pediatric patients.
  • A lecture and discussion around SUDEP.


For more information, email [email protected].

 

Hina Dave, MD
Course Co-Director
Associate Professor
Department of Neurology
McGovern Medical School at UTHealth
Jay Gavvala, MD, MSCI
Course Co-Director
Associate Professor
Department of Neurology
McGovern Medical School at UTHealth
Picture of Samden Lhatoo
Samden Lhatoo, MD
Director, Texas Comprehensive Epilepsy Program
Co-Director, Texas Institute for Restorative Neurotechnologies
Professor and Executive Vice Chair, Department of Neurology
John P. and Kathrine G. McGovern Distinguished Chair
McGovern Medical School at UTHealth Houston
Picture of Nitin Tandon
Nitin Tandon, MD
Co-Director, Texas Comprehensive Epilepsy Program
Co-Director, Texas Institute for Restorative Neurotechnologies
Professor, Vivian L. Smith Department of Neurosurgery
BCMS Distinguished Professor in Neurological Disorders and Neurosurgery
McGovern Medical School at UTHealth Houston

Learning Objectives

  1. Identify clinical features that support a diagnosis of epilepsy and specific epilepsy syndromes.
  2. Recognize normal, abnormal and epileptiform EEG patterns.
  3. Appropriately choose antiseizure medications for patients with epilepsy based on clinical history, comorbidities and epilepsy subtype.
  4. Identify appropriate diagnostic testing in persons with epilepsy including testing in drug resistant epilepsy patients.

Accreditation Statement/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Antidote Education Company and UTHealth Houston Neurosciences. Antidote is accredited by the ACCME to provide continuing medical education for physicians.

Antidote designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For more information, email [email protected].